SXTP | NASDAQ

60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc. (SXTP) | runway 8.9 months | financing risk high | market cap $4.2M. Daily snapshot of financials, capital pressure, and rec...

Company websiteLast updated Apr 29, 2026

Share price

$1.57

As of Apr 29, 2026

Market cap

$4.2M

Snapshot valuation

30D volume

248,088 shares

Rolling average daily volume

Runway

8.9 months

Estimated from precomputed burn and cash

Financing risk

N/A

The company screens as likely to return to the capital markets soon.

Snapshot summary

Runway: 8.9 months based on estimated burn.

Recent financing detected on Mar 12, 2026.

Financing signal: The company screens as likely to return to the capital markets soon.

Recent developments

60 DEGREES PHARMACEUTICALS, INC. 10-K 2026-03-30

10-K filed on 2026-03-30.

Mar 29, 2026, 8:00 PM

60 DEGREES PHARMACEUTICALS, INC. 8-K 2026-03-20

8-K filed on 2026-03-20.

Mar 19, 2026, 8:00 PM

60 DEGREES PHARMACEUTICALS, INC. 8-K 2026-03-13

8-K filed on 2026-03-13.

Mar 12, 2026, 8:00 PM

60 DEGREES PHARMACEUTICALS, INC. 424B5 2026-03-13

424B5 filing submitted on 2026-03-13.

Mar 12, 2026, 8:00 PM

60 DEGREES PHARMACEUTICALS, INC. 8-K 2026-03-12

8-K filed on 2026-03-12.

Mar 11, 2026, 8:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures